Hyalex Highlight ?? ? Congratulations to Dr. Deryk Jones for enrolling his first Hyalex knee patient in our FDA IDE-Approved clinical study! Dr. Jones is currently recruiting additional patients in the Hyalex clinical study for knee cartilage repair at Ochsner Health Sports Medicine Institute.? ? Hyalex Chief Medical Officer Dr. Thomas Vail and VP of Clin/Reg Chris Cain were down in New Orleans for this exciting milestone. ? As we kick off a busy fall at Hyalex, our knee cartilage trial is now underway at 4 sites in the US as well as 2 sites in Europe. Learn more about these clinical studies of our off-the-shelf synthetic cartilage technology by visiting the Hyalex website: https://lnkd.in/e4qsPzFh ? Note: Investigational Device. Limited by Federal (or United States) law to investigational use. #medicaldevice #orthopedics #LSIAlumni
Hyalex Orthopaedics Inc.
医疗设备制造业
Transforming orthopaedics with breakthrough synthetic cartilage technology
关于我们
Hyalex Orthopaedics is a venture backed Boston-based medical device start-up focused on developing and commercializing new products that feature HYALEX? materials technology. Unlike other polymers, synthetic HYALEX material has the unique capability of maintaining low friction and low wear under the high loads encountered in human joints. Hyalex Orthopaedics’ knee implant is an investigational device limited by Federal (or United States) law to investigational use.
- 网站
-
https://www.hyalex.com
Hyalex Orthopaedics Inc.的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 11-50 人
- 类型
- 私人持股
- 创立
- 2016
- 领域
- polymer science、orthopaedics、medical devices、surgical products、chemistry、research and development和cartilage
地点
Hyalex Orthopaedics Inc.员工
动态
-
Hyalex is gearing up for an exciting conference next week. Our CEO Carl Vause will be presenting our latest technology and clinical trial progress on Wednesday September 18th - let us know if you'll be in Portugal! #medtech #healthtech #orthopedics #medicaldevice #BeActiveStayActive
Hyalex Orthopaedics Inc.(#LSIEurope24 Innovator) has developed a disruptive synthetic materials platform that mimics the structure and function of native cartilage to help patients suffering from diseased and damaged joints. The company aims to immediately restore damaged joint surfaces in a single straightforward surgery to get patients pain-free and back to their active lifestyles as quickly and reliably as possible. The Hyalex Knee Implant has been designed to address a neglected segment of the population known as the “Cartilage Gap” – patients between age 35 and 65 who have painful knee lesions but are too old to rely on unpredictable regenerative techniques and too young for total joint replacement. The Hyalex Knee Implant has received FDA Breakthrough Designation and FDA IDE approval. Hyalex is currently enrolling patients in knee clinical trials in the US and EU, with clinically significant improvements in patient outcomes being reported at the earliest validated time points in both studies. The Hyalex MTP Implant leverages the same impressive biomimetic technology platform to tackle the massive unmet need in Great Toe arthritis, which is estimated to affect more than 3 million people in the US alone. The MTP Implant is in the final stages of development, with FDA 510(k) submission planned before the end of this year. We’re excited to announce that CEO, Carl Vause has been selected to present Hyalex at LSI Europe ‘24 this September 16-20th in Sintra, Portugal. Hyalex has experienced significant momentum over the last 12 months and Carl Vause is looking forward to sharing new data on its major clinical milestones at the event.
-
-
At Hyalex Orthopaedics, our goal is to improve patient quality of life by using our incredible HYALEX Cartilage technology to restore pain-free motion in a variety of joints throughout the body. Our Hyalex Knee Implant is just the beginning! Our design team was hard at work in Chicago last week developing the next phase of Hyalex implants with some outstanding clinical partners. Thanks to Graymont Medical for the use of their state-of-the-art lab space. Follow along with our progress and check out our website for more info on our ongoing clinical study for knee joint surface restoration: https://lnkd.in/e4qsPzFh
-
-
Hyalex CEO Carl Vause and VP of Clin/Reg Chris Cain are back from Denver and reflecting on a few great days reconnecting with physicians and other industry leaders at #AOSSM2024 last week to share the progress of our Hyalex Knee clinical trials and platform pipeline. The American Orthopaedic Society for Sports Medicine conference is always an amazing opportunity to learn and network with some of the brightest minds in the industry, and this year was no exception. Cartilage repair continues to be one of the largest unmet needs for surgeons and patients, and we were able to share some exciting news of our own from the ongoing clinical trials of our off-the-shelf Hyalex Knee Implant. The Hyalex Knee Trial is enrolling in the US with Dr. Dennis Crawford MD, PhD at Oregon Health and Science University in Portland, Oregon and Dr. Sabrina Strickland, MD and Dr. Andreas Gomoll, MD at Hospital for Special Surgery in New York City. Learn more on our website at https://lnkd.in/e4qsPzFh
-
Hyalex Highlight ?? ? The Hyalex team was back in Portland Oregon last month! Congratulations to Dr. Dennis Crawford MD, PhD and team at Oregon Health and Science University for enrolling the very first US patients in the Hyalex FDA IDE-Approved clinical study. Dr. Crawford is currently enrolling additional patients in our clinical study for knee cartilage repair. ? Learn more about the clinical studies of our off-the-shelf synthetic cartilage technology by visiting the Hyalex Orthopaedics website: https://lnkd.in/e4qsPzFh ? Note: Investigational Device. Limited by Federal (or United States) law to investigational use.
-
-
Hyalex Highlight ?? ? Congratulations to Professor Marcin Domzalski and team at Sporto Clinic in Lodz, Poland on making history by enrolling the first-ever patients in the Hyalex First-in-Human clinical study earlier this year. Professor Domzalski is currently enrolling additional patients in our European clinicial trial for knee cartilage repair. ? Hyalex is honored to be working with renowned surgeons both in Europe and in the US. Our off-the-shelf synthetic cartilage implant is designed to help patients with knee cartilage injury. To learn more about our ongoing clinical trials, please visit our website: https://lnkd.in/e4qsPzFh ? Note: Investigational Device. Limited by Federal (or United States) law to investigational use.
-
-
Hyalex Orthopaedics Inc. is officially in the clinic! We have successfully enrolled patients in the first-in-human clinical trials of our novel HYALEX Knee Cartilage System in both the US and Europe. This is a major milestone for our company and it's our mission to bring this innovative technology to all of the surgeons and patients who need it. Read the full press release here:?https://lnkd.in/eAfgQ5n8
-
-
Exciting news about our Hyalex leadership team and board of directors - read the full press release here! https://lnkd.in/erhwmRZ5
-
At?Hyalex Orthopaedics Inc.?we’re leveraging our proprietary HYALEX material to solve one of the biggest unmet needs in medicine, cartilage repair. Building a great team with great employees is critical to our success. For the last quarter, we’d like to say a big congratulations to Bridget Cona?the winner of the Q4 2023 Hyalex High Honors (H3) award. This award is given every quarter to the Hyalex employee who has most exemplified our Corporate Values of Integrity, Innovation, Accountability, Teamwork, and Communication. Bridget was recognized by her peers as demonstrating the corporate values through her exceptional teamwork in process improvements, leadership in experimentation protocol development, engineering report writing, and test method validation execution all which support the advancement of the Hyalex mission. The Hyalex team recognizes her thoughtful and impactful feedback on multiple engineering initiatives not just over the last quarter, but throughout the year. Bridget's efforts positively impact the entire company and we appreciate her unique skillset that from which we all continue to learn and improve. It’s an honor to have Bridget part of our?Hyalex Orthopaedics Inc.?team and now recognize her with the Q4 2023 Hyalex High Honors award. Thank you and keep up the outstanding work,?Bridget Cona. ? #hyalex?#beactivestayactive?#orthopedics?#orthopaedics?#orthopedicsurgeon?#orthopedicsurgery?#medicaldevice?#medtech?#medtechinnovator?#employeerecognition?#employeeappreciation?#teamwork?#thankyou?#recognition?#recognitionawards?#corporatevalues?#excellence?#award?#innovation?#engineering?#entrepreneurship?#leadership?#awards?#werehiring?#comeworkwithus?#joinourteam?#hiring?#team?#development?#work?#communication
-
-
Carl Vause, Hyalex's president and chief executive officer, will deliver a corporate presentation as part of the Canaccord Genuity 2024 Musculoskeletal Conference. The conference will take place in?San Francisco, California, on?Monday, February 12, 2024. Mr. Vause's presentation is scheduled for?10:30 a.m. PT?and will include an update on the company's development of the novel HYALEX Cartilage platform, the company's product pipeline, and clinical roadmap. A live webcast of the presentation can be accessed through the following link:?https://lnkd.in/d3Qp-gy6
CG 2024 Musculoskeletal Conference
wsw.com